证券代码：301509 证券简称：金凯生科 公告编号：2025-039 金凯（辽宁）生命科技股份有限公司 关于公司股东减持股份的预披露公告 股东启鹭（厦门）股权投资合伙企业（有限合伙）、青岛青松创业投资集团 有限公司－青岛松凯创业投资企业（有限合伙）、蓝色经济区产业投资基金（有 限合伙）保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 金凯（辽宁）生命科技股份有限公司（以下简称"公司"）股东启鹭（厦门）股权 投资合伙企业（有限合伙）（以下简称"启鹭投资"）持有公司股份5,936,580股（占 公司总股本比例4.93%）。启鹭投资计划通过集中竞价和大宗交易方式减持公司股份不 超过3,612,000股（占公司总股本比例3%）。其中，通过集中竞价方式减持股份不超过 1,204,000股，减持比例不超过公司总股本的1%；通过大宗交易方式减持股份不超过 2,408,000股，减持比例不超过公司总股本的2%。集中竞价的减持期间为自本减持计划 公告之日起十五个交易日后的三个月内；大宗交易的减持期间为自本减持计划 ...

Group 1 - The company Jin Kai Sheng Ke stated that as of November 10, 2025, the number of shareholders is expected to be 14,577 [2]

Core Viewpoint - Taihu Xue Company has been awarded the "Most Socially Responsible Listed Company" for its commitment to community development, environmental sustainability, and cultural heritage through innovative practices and industry integration [4][7]. Group 1: Social Responsibility Initiatives - The company has established an ESG committee at the board level to oversee sustainable development strategies and respond to stakeholder expectations [5]. - In response to a natural disaster, Taihu Xue donated over 100,000 yuan worth of bedding supplies to a school in Guizhou province, ensuring children had warm bedding for the winter [5]. Group 2: Industry Integration and Cultural Heritage - Taihu Xue has developed the Taihu Xue Silkworm Culture Park, which combines modern agriculture, silk processing, and cultural tourism, significantly improving the efficiency of silk production [6]. - The company invested 17.91% more in R&D in the first three quarters of 2025, totaling 17.67 million yuan, to enhance silk product offerings and promote Suzhou's cultural heritage through collaborations with local museums [6]. Group 3: Governance and Risk Management - The company has implemented comprehensive risk management procedures to enhance its ability to predict and control risks related to quality, environment, and occupational health [5]. - The governance structure is seen as a foundation for fulfilling social responsibilities, with ongoing improvements to internal control systems [5].

Core Viewpoint - Jinkai Biological (301509) is evaluating the application potential of aromatic amines, which are commonly used organic synthesis intermediates [1] Company Summary - Jinkai Biological has acknowledged the relevance of aromatic amines in organic synthesis and is currently assessing their technological applications [1]

Core Insights - Jinkai Biotechnology, established on June 8, 2009, went public on August 3, 2023, on the Shenzhen Stock Exchange, focusing on small molecule CDMO services in the global life sciences sector [1] - The company provides custom R&D and production services for small molecule drug intermediates and a limited amount of active pharmaceutical ingredients for global innovative drug manufacturers [1] Financial Performance - For Q3 2025, Jinkai Biotechnology reported revenue of 488 million yuan, ranking 21st among 29 peers, with the industry leader WuXi AppTec at 32.857 billion yuan and the average revenue at 2.547 billion yuan [2] - The net profit for the same period was 103 million yuan, placing the company 11th in the industry, with the top performer WuXi AppTec at 12.206 billion yuan and the industry average at 585 million yuan [2] Financial Ratios - As of Q3 2025, the company's debt-to-asset ratio was 5.22%, down from 6.33% year-on-year, significantly lower than the industry average of 22.79%, indicating strong solvency [3] - The gross profit margin for the same period was 47.43%, up from 39.11% year-on-year, surpassing the industry average of 37.70%, reflecting robust profitability [3] Executive Compensation - The chairman and CEO, Fumin Wang, received a salary of 3.2117 million yuan in 2024, an increase of 225,900 yuan from 2023 [4] Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 1.48% to 14,100, while the average number of circulating A-shares held per shareholder increased by 1.50% to 4,027.61 [5]

关于开立募集资金现金管理专用结算账户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 金凯（辽宁）生命科技股份有限公司（以下简称"公司"或"金凯生科"）于 2025年8月22日召开第二届董事会第八次会议、第二届监事会第八次会议，于2025 年9月22日召开2025年第一次临时股东会，审议通过了《关于使用部分闲置募集资 金（含超募资金）及自有资金进行现金管理的议案》，同意公司在确保不影响募集 资金投资项目建设需要和公司正常经营、并有效控制风险的前提下，公司拟使用不 超过人民币9亿元（含本数）的暂时闲置募集资金（含超募资金）及不超过人民币7 亿元（含本数）的自有资金进行现金管理。上述额度的有效期自公司股东会审议通 过之日起12个月内有效。在上述额度和期限范围内，资金可以循环滚动使用。暂时 闲置募集资金（含超募资金）现金管理到期后将及时归还至募集资金专户。保荐人 出具了无异议的核查意见。具体内容详见公司于2025年8月23日刊登在巨潮资讯网 （www.cninfo.com.cn）上的《关于使用部分闲置募集资金（含超募资金）及自有 资金进行现金管理的公告》（公告 ...

Group 1: Company Performance Highlights - Ecovacs Robotics reported a significant increase in Q3 2025 revenue of 4.201 billion yuan, up 29.26% year-on-year, and a net profit of 438 million yuan, up 7160.87% [1] - Deep South Housing A achieved a revenue of approximately 898.85 million yuan in the first three quarters of 2025, a year-on-year increase of 331.66%, with a net profit of about 145.12 million yuan, up 2791.57% [1] - Antong Holdings reported Q3 2025 revenue of 2.152 billion yuan, an 18.85% increase year-on-year, and a net profit of 152 million yuan, up 2155.18% [2] - Sichuan Changhong's Q3 2025 revenue was 25.184 billion yuan, down 2.69% year-on-year, but net profit increased to 507 million yuan, up 690.83% [2] - Zhenghai Magnetic Materials reported a revenue of approximately 4.973 billion yuan for the first three quarters of 2025, a 30.54% increase, with a net profit of about 228 million yuan, up 20.46% [3] - Gold Mountain reported Q3 2025 revenue of 3.372 billion yuan, up 66.39% year-on-year, and a net profit of 951 million yuan, up 140.98% [4] Group 2: Corporate Actions and Strategic Moves - Yiyi Co. plans to acquire 100% equity of Gao Ye Jia, with the stock resuming trading on October 27 [6][8] - Ying Tang Zhi Kong is planning to issue shares to acquire assets, leading to a stock suspension starting October 27 [18][35] - Dream Jie Co. faced dissent from board member Chen Jie regarding the Q3 2025 report, raising concerns about its accuracy and completeness [9] - Drugmaker WuXi AppTec intends to sell 100% equity of two subsidiaries for 2.8 billion yuan to focus on its CRDMO business model [20][21] - Huayi Technology is planning to invest in a new project with a budget of approximately 266.65 million yuan for advanced manufacturing capabilities [22]

Financial Performance Highlights - San Chuan Wisdom reported a net profit of 143.89 million yuan, a year-on-year increase of 101.23%, with total revenue of 827.84 million yuan, down 25.53% [1] - Dian Guang Media achieved a net profit of 132.11 million yuan, up 116.61%, with revenue of 3.19 billion yuan, an increase of 16.32% [1] - Jin Kai BioScience's net profit surged by 163.24% to 103.43 million yuan, with revenue of 487.72 million yuan, up 25.96% [2] - He Ren Technology's net profit skyrocketed by 1,292.86% to 12.94 million yuan, despite a slight revenue decline of 0.33% to 263.46 million yuan [3] - Ming Tai Aluminum's net profit for Q3 increased by 35.94% to 464 million yuan, while total revenue for the first three quarters was 25.87 billion yuan, up 9.38% [4] - Jin Cai Interconnect reported a staggering net profit growth of 1,697.84% to 57.52 million yuan, with revenue of 750.02 million yuan, down 17.32% [5] - Chi Feng Gold's Q3 net profit rose by 140.98% to 951 million yuan, with revenue of 3.37 billion yuan, up 66.39% [6] - Chu Jiang New Materials reported a net profit of 355.17 million yuan, a year-on-year increase of 2,089.49%, with revenue of 44.19 billion yuan, up 13.29% [8] - Guo Xuan High-Tech's net profit increased by 514.35% to 2.53 billion yuan, with revenue of 29.51 billion yuan, up 17.21% [16] - Sichuan Changhong's Q3 net profit grew by 690.83% to 50.7 million yuan, despite a revenue decline of 2.69% to 25.18 billion yuan [17] - Kewo Technology's Q3 net profit surged by 7,161% to 438 million yuan, with revenue of 4.20 billion yuan, up 29.26% [16] Strategic Developments - GreenMei signed a strategic cooperation framework agreement with Xiamen Xatong New Energy to supply 150,000 tons of battery materials annually from 2026 to 2028 [4] - Hunan Development plans to invest 2.4 billion yuan in a photovoltaic power generation project with a capacity of 800MW [9] - Weston intends to use 160 million yuan of raised funds to acquire and increase investment in Liangtou Technology, aiming for a controlling stake [7] - Zhaopin Technology announced a joint investment with Zhizhu and Yuankeshi to establish Shenzhen Zhixian Robot Technology Co., with a registered capital of 50 million yuan [12] - Jiangsu Long Power's controlling shareholder secured a loan of up to 7.2 billion yuan specifically for stock repurchase [22][23]

Core Viewpoint - The article summarizes significant announcements from various listed companies in the Shanghai and Shenzhen stock markets, highlighting investment opportunities and financial performance. Group 1: Major Announcements - Yueda Investment has established joint ventures with China Resources Power and others to invest in offshore wind power projects, holding 20% and 30% stakes in two projects with total investments of 2 billion and 3.9 billion yuan respectively, enhancing its position in the renewable energy sector [4] - Hunan Development plans to invest 2.4 billion yuan in a photovoltaic power generation project with a capacity of 800MW, scheduled for construction from 2026 to 2029 [8] - Longjiang Power's controlling shareholder has received a loan commitment of up to 7.2 billion yuan for stock repurchase, with 2.531 billion yuan already spent on acquiring shares [9] - Huitong Co. plans to invest 81 million yuan in a high-temperature nylon and PEEK polymerization project [10] - Wiston intends to acquire a 36.7483% stake in Liangtou Technology and increase its investment, making it a subsidiary [11] Group 2: Financial Performance - Jincai Hulin reported a net profit increase of 1697.84% year-on-year for the first three quarters, despite a revenue decline of 17.32% [15] - Guoxuan High-Tech's net profit surged by 1434.42% in Q3, with a revenue increase of 20.68% [16] - Tian'ao Electronics achieved a net profit growth of 1329.08% in Q3, despite a revenue decline [18] - Morning Light Bio's net profit increased by 385.3% year-on-year for the first three quarters, despite a slight revenue decline [19] - Donggang Co. reported a net profit increase of 373.51% in Q3, driven by growth in its smart card and printing businesses [20] Group 3: Other Notable Financial Results - Xinjiang Tianye's Q3 net profit rose by 363.19%, while its revenue increased by 8.6% [21] - Jinkai Biotechnology reported a net profit growth of 339.92% in Q3, with a revenue increase of 11.27% [22] - Antong Holdings saw a net profit increase of 311.77% in Q3, with a revenue growth of 18.85% [23] - Wen Tai Technology's net profit grew by 265.09% in Q3, despite a significant revenue decline [25] - Chahua Co. reported a 240.5% increase in Q3 revenue, driven by business restructuring [27]

Group 1: Financial Performance - Dongfang Caifu reported a Q3 revenue of 4.733 billion yuan, a year-on-year increase of 100.65%, and a net profit of 3.53 billion yuan, up 77.74% year-on-year [1] - Guoxuan High-Tech announced a Q3 revenue of 10.114 billion yuan, a 20.68% increase year-on-year, and a net profit of 2.167 billion yuan, soaring 1434.42% year-on-year [2] - Jiangsu Power's controlling shareholder received a loan commitment of up to 7.2 billion yuan for stock repurchase [3] - Yueda Investment reported a Q3 revenue of 789 million yuan, a 22.97% increase year-on-year, and a net profit of 615.22 million yuan, up 333.60% year-on-year [4] Group 2: Strategic Investments - Yueda Investment formed joint ventures with China Resources Power and others to invest in offshore wind power projects, holding 20% and 30% stakes in two projects [4] - Hunan Development signed an investment agreement for a photovoltaic power generation project with a total investment of approximately 2.4 billion yuan [7] - Wiston plans to acquire a 36.7483% stake in Liangtou Technology and increase its capital, making it a subsidiary [10] Group 3: Market Trends and Risks - Shannon Chip announced significant stock price volatility, with a cumulative deviation of over 200% in 30 trading days, indicating potential irrational speculation [5] - Cambridge Technology set its H-share issuance price at 68.88 HKD per share, with trading expected to start on October 28, 2025 [6] Group 4: Company-Specific Developments - Jin Cai Hulin reported a Q3 net profit increase of 1697.84% despite a revenue decline [11] - Morning Light Bio's Q3 net profit grew by 385.3% despite a revenue drop [12] - Donggang Co. reported a Q3 net profit increase of 373.51% with a revenue increase of 45.80% [13] - Xinjiang Tianye's Q3 net profit increased by 363.19% despite a revenue increase of only 8.6% [14]